stanozolol

GPTKB entity

Statements (37)
Predicate Object
gptkbp:instanceOf anabolic steroid
gptkbp:administeredBy oral
intramuscular injection
gptkbp:bannedIn gptkb:World_Anti-Doping_Agency
gptkbp:CASNumber 10418-03-8
gptkbp:category gptkb:veterinary_medicine
androgen
performance-enhancing drug
anabolic agent
World Anti-Doping Agency prohibited substance
synthetic steroid
gptkbp:chemicalFormula C21H32N2O
gptkbp:detects gptkb:Ben_Johnson_(1988_Olympics)
gptkbp:developedBy gptkb:Winthrop_Laboratories
https://www.w3.org/2000/01/rdf-schema#label stanozolol
gptkbp:introduced 1962
gptkbp:IUPACName (17β)-17-hydroxy-2'H-androst-2-eno[3,2-c]pyrazol-17-yl acetate
gptkbp:legalStatus Schedule III controlled substance in the United States
gptkbp:marketedAs gptkb:Winstrol
gptkbp:metabolism liver
gptkbp:molecularWeight 328.5 g/mol
gptkbp:notableCase gptkb:Lance_Armstrong_investigation
gptkb:Chris_Benoit_case
gptkb:Marion_Jones_doping_scandal
gptkb:Rafael_Palmeiro_suspension
gptkbp:sideEffect hair loss
acne
voice changes
liver toxicity
increased risk of cardiovascular disease
gptkbp:used_in athletes for performance enhancement
gptkbp:usedFor gptkb:veterinary_medicine
treatment of anemia
treatment of hereditary angioedema
gptkbp:bfsParent gptkb:anabolic_steroids
gptkb:Ben_Johnson_doping_scandal
gptkbp:bfsLayer 7